146 related articles for article (PubMed ID: 35007784)
21. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice.
Rostamian M; Niknam HM
Mol Immunol; 2017 Nov; 91():202-208. PubMed ID: 28963929
[TBL] [Abstract][Full Text] [Related]
22. Pre-activation with TLR7 in combination with thioridazine and loratadine promotes tumoricidal T-cell activity in colorectal cancer.
Lin X; Zhang J; Wang X; Lin G; Chen T
Anticancer Drugs; 2020 Nov; 31(10):989-996. PubMed ID: 32694422
[TBL] [Abstract][Full Text] [Related]
23. TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs.
Adzavon YM; Zhao P; Lv B; Liu M; Zhang X; Xie F; Yang L; Shang L; Zhang M; Li Q; Ma X
Cytokine; 2017 Sep; 97():156-166. PubMed ID: 28648870
[TBL] [Abstract][Full Text] [Related]
24. IL-27 Is Essential for Suppression of Experimental Allergic Asthma by the TLR7/8 Agonist R848 (Resiquimod).
Jirmo AC; Daluege K; Happle C; Albrecht M; Dittrich AM; Busse M; Habener A; Skuljec J; Hansen G
J Immunol; 2016 Dec; 197(11):4219-4227. PubMed ID: 27799314
[TBL] [Abstract][Full Text] [Related]
25. Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy.
Zhang H; Tang WL; Kheirolomoom A; Fite BZ; Wu B; Lau K; Baikoghli M; Raie MN; Tumbale SK; Foiret J; Ingham ES; Mahakian LM; Tam SM; Cheng RH; Borowsky AD; Ferrara KW
J Control Release; 2021 Feb; 330():1080-1094. PubMed ID: 33189786
[TBL] [Abstract][Full Text] [Related]
26. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
[TBL] [Abstract][Full Text] [Related]
27. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
28. A Squalene-Based Nanoemulsion for Therapeutic Delivery of Resiquimod.
Zhang Z; Kuo JC; Zhang C; Huang Y; Zhou Z; Lee RJ
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959344
[TBL] [Abstract][Full Text] [Related]
29. Gold Nanorods and Polymer Micelles Mediated Dual TLR Stimulators Delivery System CPG@Au NRs/M-R848 Regulate Macrophages Reprogramming and DC Maturation for Enhanced Photothermal Immunotherapy of Melanoma.
Jia Y; Shi K; Dai L; He X; Deng H; Han R; Yang F; Chu B; Liao J; Wei X; Qian Z
Small Methods; 2023 May; 7(5):e2201087. PubMed ID: 36572641
[TBL] [Abstract][Full Text] [Related]
30. Novel delivery of sorafenib by natural killer cell-derived exosomes-enhanced apoptosis in triple-negative breast cancer.
Hashemi ZS; Ghavami M; Kiaie SH; Mohammadi F; Barough MS; Khalili S; Hosseini-Farjam Z; Mossahebi-Mohammadi M; Sheidary A; Ghavamzadeh A; Forooshani RS
Nanomedicine (Lond); 2023 Feb; 18(5):437-453. PubMed ID: 37199259
[TBL] [Abstract][Full Text] [Related]
31. Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance.
Bourquin C; Hotz C; Noerenberg D; Voelkl A; Heidegger S; Roetzer LC; Storch B; Sandholzer N; Wurzenberger C; Anz D; Endres S
Cancer Res; 2011 Aug; 71(15):5123-33. PubMed ID: 21697281
[TBL] [Abstract][Full Text] [Related]
32. Radioresponsive Delivery of Toll-like Receptor 7/8 Agonist for Tumor Radioimmunotherapy Enabled by Core-Cross-Linked Diselenide Nanoparticles.
Wu Y; Qin J; Gu Y; Zhao G; Xu P; Lin S; Cheng X; Zhang LW; Wang Y; Wang Y
ACS Nano; 2024 Jan; 18(4):2800-2814. PubMed ID: 38227969
[TBL] [Abstract][Full Text] [Related]
33. Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation.
Bhagchandani SH; Vohidov F; Milling LE; Tong EY; Brown CM; Ramseier ML; Liu B; Fessenden TB; Nguyen HV; Kiel GR; Won L; Langer RS; Spranger S; Shalek AK; Irvine DJ; Johnson JA
Sci Adv; 2023 Apr; 9(16):eadg2239. PubMed ID: 37075115
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA engineered umbilical cord stem cell-derived exosomes direct tendon regeneration by mTOR signaling.
Yao Z; Li J; Xiong H; Cui H; Ning J; Wang S; Ouyang X; Qian Y; Fan C
J Nanobiotechnology; 2021 Jun; 19(1):169. PubMed ID: 34090456
[TBL] [Abstract][Full Text] [Related]
35. Self-assembling peptide for co-delivery of HIV-1 CD8+ T cells epitope and Toll-like receptor 7/8 agonists R848 to induce maturation of monocyte derived dendritic cell and augment polyfunctional cytotoxic T lymphocyte (CTL) response.
Ding Y; Liu J; Lu S; Igweze J; Xu W; Kuang D; Zealey C; Liu D; Gregor A; Bozorgzad A; Zhang L; Yue E; Mujib S; Ostrowski M; Chen P
J Control Release; 2016 Aug; 236():22-30. PubMed ID: 27297778
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model.
Koh J; Kim S; Lee SN; Kim SY; Kim JE; Lee KY; Kim MS; Heo JY; Park YM; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Yang S; Ha SJ; Lim YT; Ahn MJ
Nanomedicine; 2021 Oct; 37():102415. PubMed ID: 34174421
[TBL] [Abstract][Full Text] [Related]
37. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
Liang L; Zhao L; Wang Y; Wang Y
Mol Pharm; 2021 Mar; 18(3):1003-1013. PubMed ID: 33527831
[TBL] [Abstract][Full Text] [Related]
38. Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis.
Tavakoli Dargani Z; Singla DK
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H460-H471. PubMed ID: 31172809
[TBL] [Abstract][Full Text] [Related]
39. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy.
Rodell CB; Arlauckas SP; Cuccarese MF; Garris CS; Li R; Ahmed MS; Kohler RH; Pittet MJ; Weissleder R
Nat Biomed Eng; 2018 Aug; 2(8):578-588. PubMed ID: 31015631
[TBL] [Abstract][Full Text] [Related]
40. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
